Driving a decade of change: HIV/AIDS, patents and access to medicines for all
Open Access
- 1 January 2011
- journal article
- review article
- Published by Wiley in Journal of the International AIDS Society
- Vol. 14 (1) , 15
- https://doi.org/10.1186/1758-2652-14-15
Abstract
Since 2000, access to antiretroviral drugs to treat HIV infection has dramatically increased to reach more than five million people in developing countries. Essential to this achievement was the dramatic reduction in antiretroviral prices, a result of global political mobilization that cleared the way for competitive production of generic versions of widely patented medicines.Keywords
This publication has 57 references indexed in Scilit:
- Expansion of cancer care and control in countries of low and middle income: a call to actionThe Lancet, 2010
- Quantifying the Impoverishing Effects of Purchasing Medicines: A Cross-Country Comparison of the Affordability of Medicines in the Developing WorldPLoS Medicine, 2010
- Implications of Patent Pools on Innovation Regarding Antiretrovirals§The Open AIDS Journal, 2010
- Patent Pools for ARVs: Industry Perspectives from ASPENThe Open AIDS Journal, 2010
- The UNITAID Patent Pool Initiative: Bringing Patents Together for the Common GoodThe Open AIDS Journal, 2010
- Towards a Patent Pool for HIV Medicines: The BackgroundThe Open AIDS Journal, 2010
- A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countriesJournal of the International AIDS Society, 2010
- Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines marketsGlobalization and Health, 2010
- Task Shifting for Scale-up of HIV Care: Evaluation of Nurse-Centered Antiretroviral Treatment at Rural Health Centers in RwandaPLoS Medicine, 2009
- A New Trade Framework for Global Healthcare R&DPLoS Biology, 2004